Tuesday 24 January 2017

Brain Perfusion Scanners Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

A brain perfusion scan is a type of brain test that provides information about brain function by demonstrating the amount of blood taken up by the brain cells and measure perfusion in the brain. Measuring perfusion is important for identification and treatment of stroke, other blood vessel diseases of the brain and brain tumors. Brain perfusion scan, require a radiotracer and nonradioactive substance for scanning of the brain. Factors such as, technological advancements in devices, increasing awareness about neurodegenerative diseases, the increasing incidence and prevalence of neurological disorders and growing incidence of brain injuries are driving the Brain perfusion scanners market. On the other hand, factors such as high cost of complex devices, shortage of trained professionals and concerns regarding the accuracy of diagnostic devices may hinder the growth of Brain perfusion scanners market. Some brain perfusion scan requires exposure you to radiation which increases the risk for cancer.
Brain Perfusion Scanners are used in different types of neurological indications such as Epilepsy, Dementia brain tumor, etc. According to WHO one billion peoples suffering from neurological disorders worldwide, 50 million suffer from epilepsy and 24 million from Alzheimer and 6.8 million people die every year as a result of neurological disorders. Brain perfusion takes only 60-75 second time to image the circulation in the brain. Some areas of the brain that are very active often show greater blood supply, so brain perfusion scanner also tracks these increase areas of the brain where blood supply is high and according to that a patient get treated.
The Global Brain perfusion scanners market is segmented by product type, Indication, End users and regional presence:
Segmentation based on product type
  • Single Photon Emission Tomography (SPECT)
  • Positron Emission Tomography (PET)
  • Computed Tomography (CT)
  • Magnetic resonance imaging (MRI).
Segmentation based on Indication
  • Epilepsy
  • Dementia
  • Stroke or transient ischemic attack
  • Subarachnoid hemorrhage
  • Carotid stenosis
  • Cerebral vasculitis
  • Brain tumor
  • Recent head injury
Segmentation based on End users
  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers
  • Diagnostic Labs and Imaging centers
Geographically the Brain perfusion scanners market is segmented into five key regions: North America, Latin America, Europe, APEJ, and MEA region. Magnetic resonance imaging (MRI) is highly used in brain diffusion scan followed by CT scan. MRI uses magnets and radio waves that show clearer images of brain tissue whereas CT scans used specialized kind of X-ray. Diffusion MRI measures molecular water motion in the tissue, showing where water diffusion is restricted and the cause of brain damage. According to American Academy of Neurology, the guidelines found in MRI scans are more accurately detect lesions from stroke and helped to identify the severity of stroke and other medical conditions.
North America dominates the Brain perfusion scanners market due to, the presence of strong sales and distribution network, rising incidence of various neurological disorders, government initiatives, technological advancements in the field of neurosciences and availability of insurance coverage for brain monitoring techniques. According to American Academy of Neurology, Stroke is the third leading cause of death in the United States. 5.4 million Americans are currently diagnosed with Alzheimer’s disease and will triple to 16 million by the year 2050. North America is followed by Europe and Asia-Pacific. Asia Pacific region expected to be a third largest market globally due to technological innovation, increasing healthcare expenditure and increasing insurance coverage will fuel the overall brain perfusion scanners market.
Some major companies in the Brain perfusion scanners market are General Electric, Hitachi, Ltd., NeuroLogica Corp., Neusoft Corporation, Koninklijke Philips N.V., Siemens Healthineers, Toshiba Corporation, InfraScan, Inc., Medtronic Inc. among other significant players worldwide. Technological development is the key strategy among key players, for instance, Philips lunched Ingenia 3.0T MRI Scanner in 2015, first-ever digital broadband MR system.
Posted by at No comments:

Glenoid Implant System Market: Drivers and Restraints, Segmentation, Regional Overview

Glenoid implants are mainly used for hemiarthroplasty. Hemiarthroplasty involves replacing just the joint surface of the humeral head with a cap-like prosthesis without a stem. In shoulder replacement surgery, the damaged parts of the shoulder are removed and replaced with artificial components, called a prosthesis. The treatment options are either replacement of just the head of the humerus bone (ball), or replacement of both the ball and the socket called Glenoid. Implanting the glenoid in a proper orientation is essential for long-term stability of the prosthesis. A malpositioned glenoid may have compromised fixation due to inadequate bony support or incomplete implant seating and may be subjected to increased torques on the fixation surface. The other causes for Glenoid implants are Osteoarthritis, Rheumatoid Arthritis, degenerative arthritis, Rotator Cuff Tear Arthroplasty, Avascular Necrosis, and Severe Fractures etc. According to the Agency for Healthcare Research and Quality, about 53,000 people in the U.S. have shoulder replacement surgery each year. Implantation of a glenoid component is not advised if the glenoid has good cartilage, the glenoid bone is severely deficient, and the rotator cuff tendons are irreparably torn. Glenoid Implants are available in different size, such as small, medium, large and XL. Glenoid involvement in degenerative arthritis varies depends on the type of arthritic process affecting the glenohumeral. For Instance, inflammatory arthritis is associated with central glenoid erosion. The extent and location of glenoid wear should be assessed preoperatively with axillary radiographs, axial CT scans and through the glenohumeral joint, or 3D CT reconstructions.
Achieving long-term fixation of the glenoid is a primary goal in total shoulder arthroplasty. Several methods of fixation have been attempted, including cemented, noncemented, and hybrid or minimally cemented devices. Cemented pegged and keeled components are used most commonly and are provide the most predictable fixation. Noncemented glenoids rely upon mechanical interlock and biologic integration, typically by screw fixation or a combination of screw or press-fit pegs, or both, to achieve an initial fixation that facilitates long-term bone in-growth/on-growth. According to center of disease control and prevention the prevalence of diagnosed arthritis is expected to increase among US population in the coming decades. By the year 2040, an estimated 78 million adults aged 18 years and older will have diagnosed with arthritis, compared with the 52.5 million adults in 2010-2012.
Glenoid Implant System Market: Drivers and Restraints
Factors such as Growing prevalence of symptomatic shoulder arthritis, increased patient awareness, technological advancement and expanded medical education and surgeon adoption of total shoulder replacement will fuel the overall glenoid implant market globally. According to National Health Interview Survey, 22.7 million (9.8% of all adults) have arthritis and arthritis-attributable activity limitation. Factors such as glenoid component loosening, pricing pressure, improper handling of implants are the factors will hinder the total glenoid implant market globally. Glenoid loosening is associated with increased pain, decreased shoulder function, and the need for revision surgery.
Glenoid Implant Systems Market: Segmentation
The global Glenoid implant systems market is classified on the basis of product type, Size, end user and regional presence.
Segmentation based on product type:
  • Pegged Glenoids
  • Keeled Glenoids
Segmentation based on Size:
  • Small
  • Medium
  • Large
  • XL
Segmentation based on end user:
  • Hospitals
  • Clinics
  • Orthopedic Surgery Centers
Glenoid Implant Systems Market: Regional Overview
Geographically, the global glenoid implant systems market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominates the glenoid implant systems market due to rising obese population. North America is followed by Europe and Asia Pacific. Asia Pacific is expected to grow at a highest rate due to fast disease progression, higher prevalence, improving healthcare infrastructure, economic growth, broadening insurance coverage, expanding private healthcare sector, and increasing awareness amongst people. Glenoid Implant device markets experienced a slowdown in 2012 in Japan, caused by reimbursement protocols instituted by the Japanese government.
Glenoid implant Systems Market: Key Players
Some of the major players operating in the market for global Glenoid implant are Smith & Nephew, Stryker, Zimmer, Tornier, Inc., Biomet, Exactech, Lima Corporate, Arthrex, Inc., Integra LifeSciences, DePuy Synthes, while there are a range of other smaller players as well. DePuy Synthes and Tornier represent more than half of the total market size due to its most diversified and innovated portfolios. DePuy and Tornier are expected to be the leading players in the arena for another five years
Posted by at No comments:
Labels:

Glenoid Implant System Market: Drivers and Restraints, Segmentation, Regional Overview

Glenoid implants are mainly used for hemiarthroplasty. Hemiarthroplasty involves replacing just the joint surface of the humeral head with a cap-like prosthesis without a stem. In shoulder replacement surgery, the damaged parts of the shoulder are removed and replaced with artificial components, called a prosthesis. The treatment options are either replacement of just the head of the humerus bone (ball), or replacement of both the ball and the socket called Glenoid. Implanting the glenoid in a proper orientation is essential for long-term stability of the prosthesis. A malpositioned glenoid may have compromised fixation due to inadequate bony support or incomplete implant seating and may be subjected to increased torques on the fixation surface. The other causes for Glenoid implants are Osteoarthritis, Rheumatoid Arthritis, degenerative arthritis, Rotator Cuff Tear Arthroplasty, Avascular Necrosis, and Severe Fractures etc. According to the Agency for Healthcare Research and Quality, about 53,000 people in the U.S. have shoulder replacement surgery each year. Implantation of a glenoid component is not advised if the glenoid has good cartilage, the glenoid bone is severely deficient, and the rotator cuff tendons are irreparably torn. Glenoid Implants are available in different size, such as small, medium, large and XL. Glenoid involvement in degenerative arthritis varies depends on the type of arthritic process affecting the glenohumeral. For Instance, inflammatory arthritis is associated with central glenoid erosion. The extent and location of glenoid wear should be assessed preoperatively with axillary radiographs, axial CT scans and through the glenohumeral joint, or 3D CT reconstructions.
Achieving long-term fixation of the glenoid is a primary goal in total shoulder arthroplasty. Several methods of fixation have been attempted, including cemented, noncemented, and hybrid or minimally cemented devices. Cemented pegged and keeled components are used most commonly and are provide the most predictable fixation. Noncemented glenoids rely upon mechanical interlock and biologic integration, typically by screw fixation or a combination of screw or press-fit pegs, or both, to achieve an initial fixation that facilitates long-term bone in-growth/on-growth. According to center of disease control and prevention the prevalence of diagnosed arthritis is expected to increase among US population in the coming decades. By the year 2040, an estimated 78 million adults aged 18 years and older will have diagnosed with arthritis, compared with the 52.5 million adults in 2010-2012.
Glenoid Implant System Market: Drivers and Restraints
Factors such as Growing prevalence of symptomatic shoulder arthritis, increased patient awareness, technological advancement and expanded medical education and surgeon adoption of total shoulder replacement will fuel the overall glenoid implant market globally. According to National Health Interview Survey, 22.7 million (9.8% of all adults) have arthritis and arthritis-attributable activity limitation. Factors such as glenoid component loosening, pricing pressure, improper handling of implants are the factors will hinder the total glenoid implant market globally. Glenoid loosening is associated with increased pain, decreased shoulder function, and the need for revision surgery.
Glenoid Implant Systems Market: Segmentation
The global Glenoid implant systems market is classified on the basis of product type, Size, end user and regional presence.
Segmentation based on product type:
  • Pegged Glenoids
  • Keeled Glenoids
Segmentation based on Size:
  • Small
  • Medium
  • Large
  • XL
Segmentation based on end user:
  • Hospitals
  • Clinics
  • Orthopedic Surgery Centers
Glenoid Implant Systems Market: Regional Overview
Geographically, the global glenoid implant systems market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominates the glenoid implant systems market due to rising obese population. North America is followed by Europe and Asia Pacific. Asia Pacific is expected to grow at a highest rate due to fast disease progression, higher prevalence, improving healthcare infrastructure, economic growth, broadening insurance coverage, expanding private healthcare sector, and increasing awareness amongst people. Glenoid Implant device markets experienced a slowdown in 2012 in Japan, caused by reimbursement protocols instituted by the Japanese government.
Glenoid implant Systems Market: Key Players
Some of the major players operating in the market for global Glenoid implant are Smith & Nephew, Stryker, Zimmer, Tornier, Inc., Biomet, Exactech, Lima Corporate, Arthrex, Inc., Integra LifeSciences, DePuy Synthes, while there are a range of other smaller players as well. DePuy Synthes and Tornier represent more than half of the total market size due to its most diversified and innovated portfolios. DePuy and Tornier are expected to be the leading players in the arena for another five years
Posted by at No comments:
Labels:

Aerosol Therapy Market Dynamics and Opportunities Report by Transparency Market Research

Aerosol is suspension of liquid or solid particles in a carrier gas, which makes use of it for treatment of respiratory system related diseases. Different forms of drugs can be utilized for aerosol therapy such as solid particles, liquid particles, solutions, and suspensions. Until recently, aerosol therapy concentrated primarily on treatment of asthma and COPD for which, pressurized metered-dose inhaler device was used. However, the role of aerosol therapy is expanding beyond the initial focus. This expansion eliminated CFC-based traditional metered-dose inhalers devices. This will ultimately boost the market growth of aerosol therapy in the field of gene therapy, inhalation therapy and vaccination. Aerosol therapy is a natural and easiest way to treat asthma, COPD, cystic fibrosis, and broncho pulmonary dysplasia (BPD). Aerosol therapy is also used to deliver insulin, vaccines of influenza and measles, and pain medications. Aerosol treatment therapy gives an excellent and cost-efficient drug delivery. This therapy is effective for patients who cannot use metered-dose inhalers; primary inhalation devices are produced that guarantee breath-actuated aerosol delivery with minimal side effects.
Aerosol therapy provides a fast and non-invasive way for treatment of lung disorders as the drug is delivered at the receptor site. Effectiveness of the therapy depends on how deeply aerosol particles infiltrate into the bronchial track and where the particles are deposited. A particle size under 2μm is ideal and can permeate up to the peripheral airways. That is why most commercially available aerosol devices produce droplets of roughly this size.
As per the World Health Organization, about half the cases of asthma and COPD are due to hereditary weakness and the other cases are due to environmental factors. The effect of pollution is likely to intensify globally along with industrialization of areas, and increasing the number of vehicles. Current government activities and rising healthcare investments are drivers of aerosol therapy market, which would upgrade over the examination time frame. Increasing prices are major factor that is restraining the growth of the market in terms of value.
The global market for aerosol therapy is segmented on the basis of product type, technology, disease indication, end user and geography:
  • Segmentation by product type:
  • Inhalers
  • Dry Powder Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Nebulizers
  • Ultrasonic Nebulizer
  • Compressed Air-Jet nebulizers
  • Vibrating membrane device
  • Bronchodilators
  • Segmentation by technology:
  • Manually operated
  • Digitally operated
  • Segmentation by disease indication:
  • Asthma
  • COPD
  • BPD
  • Other
  • Segmentation by end user:
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Individual
Currently metered dose inhaler majorly contributes to the market and is expected to dominate the market over the forecast period. As per the data, COPD is third leading cause of death and fifth leading cause of disability. Also, factors like increasing pollution, improper lifestyles are the factors that drive the growth of the market.
On the basis of regional presence, global aerosol therapy market is segmented into five key regions viz. North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. Asthma symptoms were detected in 26 million persons who live in the U.S., of which, 19 million comprise adults and 7 million comprise children. With this rate, North America is expected to dominate the market. Asia Pacific (mostly China and India) market is estimated to grow at a relatively fast rate over the forecast period.
The largest manufacturers of aerosol therapy devices are Merck, Boehringer Ingelheim GmbH, GlaxoSmithKline, and AstraZeneca Plc. In 2001, SmithKline Beecham and GlaxoWellcome merged together and became GlaxoSmithKline, who became a key player in this field. Also, Novartis AGTeva Pharmaceuticals, Opko Health, Omron Healthcare Co., Covidien plc., GE Healthcare Ltd., Philips Healthcare, Agilent Technologies, Inc. Ltd, GF Health Products, Inc. are other important players in this market.
Posted by at No comments:
Labels:

Blood and Fluid Warmer Market rises with growing incidences of thyroid conditions and diabetes

Normal human body temperature falls between 96.8 degrees Fahrenheit and 99.5 degrees Fahrenheit. The prolonged body exposure to cold temperature leads to hypothermia condition which drops the body temperature below 95 degrees Fahrenheit. Hypothermia can increase risk during surgeries and cause prolonged healing time. Proper patient temperature management is crucial during the patient's stay in hospitals to accelerate healing after surgeries. Therefore, hospitals and other treatment centers adopt blood and fluid warmer systems to monitor and control the core body temperature of a patient. Also, the conditions such as severe trauma, thyroid conditions, diabetes and consumption of abusive drugs can increase the risk of hypothermia. A blood and fluid warmer instrument is used to warm fluids or blood prior to transfusion to a patient during the temperature management treatment. This treatment is mostly used in operating rooms, intensive care units, and emergency settings for hypothermia prevention. Blood and fluid warmer systems enable patient treatment by maintaining normal body temperature to avoid hypothermia.
The demand for blood and fluid warming instruments is fuelled by increased burden of hypothermia cases. The incidences of hypothermia is high in cold countries. For instance, according to Center for Disease Control (CDC), in the U.S. there were around 1,301 annual deaths caused due to hypothermia. The incidence of hypothermia is high in geriatric and infant population. Worldwide a gradual increase in surgical procedures along with aging population is the major factor which is anticipated to fuel growth of the global blood and fluid warmer market during the forecast period. Also, the increasing consumption of abusive drugs, growing incidences of thyroid conditions and diabetes are the other hypothermia causing factors which are expected to boost the demand for blood and fluid warming instruments. Increase in mergers and acquisitions among the major global players is one of the major trend in the global blood and fluid warmer market. However, high research and development expenses in product development and the low awareness about blood and fluid warming instrument treatments in the developing countries is anticipated to hamper growth of the global blood and fluid warmer market growth.
The global market for blood and fluid warmer systems is segmented on basis of product, end user, application and geography:
Segmentation by Product
  • Surface Warming System
  • Intravenous Warming System
  • Patient Warming Accessories
Segmentation by Application
  • Acute Care
  • Preoperative Care
  • New Born Care
  • Home Care
  • Others (Obstetrics and Gynecology Care, etc.)
Segmentation by End User
  • Hospitals
  • Clinics
  • E-commerce
Based on product type, surface warming segment is expected to contribute largest share in global blood and fluid warming market due to increasing adoption in developed countries such as U.S, Germany and U.K. The segment is expected to grow rapidly over the forecast with increased penetration in Asia Pacific. Hospital end user segment is expected to contribute the maximum share among end users. Based on application the acute care segment is expected to contribute the maximum share owing to rise in geriatric population with different diseases.
On the basis of regional presence, global blood and fluid warmer market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to dominate the global blood and fluid warmer market in terms of value due to high demand from U.S.
Some of the major players in global human papillomavirus testing market are 3M Company, Becton, Dickinson and Company, Barkey GmbH, CareFusion, GE Healthcare, Smiths Medical, Meridian Medical Systems, The 37Company, EMIT Corporation, etc. The blood and fluid warming market is mostly dominated by some key global vendors and is expected to witness steady CAGR in terms of revenue owing to increasing adoption in the patients. This patient pool includes people suffering from chronic diseases such as thyroid conditions, and diabetes among geriatric population along with rising number of surgical procedures performed globally. The entry of existing players in emerging countries and product development with enhanced technology in the blood and fluid warming market is expected to create competition in the market.
The report covers exhaustive analysis on:
  • Blood and Fluid Warmer Market Segments
  • Blood and Fluid Warmer Market Dynamics
  • Historical Actual Market Size, 2013 - 2015
  • Blood and Fluid Warmer Market Size & Forecast 2016 to 2024
  • Blood and Fluid Warmer Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Blood and Fluid Warmer Market Drivers and Restraints
Posted by at No comments:
Labels:

Wednesday 18 January 2017

Competition Intensifies among Vendors of Neurorehabilitation Devices as Intensive Research Becomes a Priority

Transparency Market Research has published a new market report titled, “Neurorehabilitation Devices Market (Devices – Neurorobotic Systems, Brain Computer Interfaces, Non-invasive Brain Stimulators, and Wearable Devices; Applications – Stroke, Traumatic Brain Injury, Spinal Cord Injury, Parkinson’s Disease, Cerebral Palsy, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024.” According to the report, the global neurorehabilitation devices market was valued at US$ 894.9 Mn in 2015 and is anticipated to expand at a CAGR of 15.5% from 2016 to 2024 to reach US$ 3262.5 Mn by 2024.
North America and Europe dominated the global neurorehabilitation devices market in terms of revenue in 2015. Improvement in technology, growing number of neurological conditions, well-established health care infrastructure, and increasing awareness about neurorehabilitation centers are the major factors attributed to the dominance of these two regions. North America neurorehabilitation devices market is driven by increasing incidence of stroke. Large number of people in the U.S. are affected by stroke and in 2014 the affected population was approximately 6.8 million. The number is projected to reach 10 million by 2030. This is expected to boost demand for neurorehabilitation devices in North America during the forecast period from 2016 to 2024. Aging is usually associated with neurological disorders. Hence, countries termed as greying nations are likely to be the potential markets for neurorehabilitation devices. Increasing geriatric population in countries such as Germany, Spain, France, Italy, and the U.K. is driving the market in Europe.
Road traffic fatality rates are high in Asia as compared to other regions. This has led to high prevalence of traumatic brain injury. The region is also home to highest percentage of traumatic brain injury due to falls (77%), unintentional injuries (57%), and road traffic accidents (48%). These alarming number of patients demand availability of neurorehabilitation devices and thus has potential market opportunity for global as well as regional players. Moreover, the increasing incidence of stroke in Asia Pacific promises is also increasing demand for neurorehabilitation devices in Asia pacific. Asia accounts for approximately two-third of the world’s disabled population and the number is expected to increase in the next decade. However, high cost of treatment creates a barrier in seamless adoption of these devices in Asia Pacific and Latin America. Middle East & Africa is characterized by increasing demand for rehabilitation services which is ultimately going to drive the need for developed skills, effective facilities management, better use of technology, and implementation of efficient strategies in order to deliver sufficient and efficient care for neurological disorders. Hence, the midterm outlook for neurorehabilitation devices in the region is optimistic.
Major players operating in the global neurorehabilitation devices market include Medtronic plc, St. Jude Medical, Inc., Hocoma AG, AlterG, Inc., Bioness, Inc., and Ekso Bionics Holding, Inc. The key market players are actively involved in constant innovations and developments related to technology and application to cater to the multi-dimensional needs of the end-users in order to maintain their positions in the global market.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Posted by at No comments:
Labels:

Casting and Splinting (Supplies and Equipment) Market - Latest Trends & Insights 2024

According to a new market research report published by Transparency Market Research “Casting and Splinting (Supplies and Equipment) Market (Casting Products – Plaster Casts, Casting Tapes, Cast Cutters, and Casting Tools & Accessories; Splinting Products – Fiberglass Splints, Neoprene Splints, Other Splints, and Splinting tools and Accessories) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2016 – 2024” the global Casing and Splinting market was valued at US$ 1,822.4 Mn in 2015 and is estimated to reach a market value of US$ 3.1 Bn in 2024 expanding at a CAGR of 6.1% from 2016 to 2024.
A large population is prone to injuries such as orthopedic, musculoskeletal, and sports injury and require casting and/or splinting products for healing. The casting and splinting market is driven by high incidence of accidents, trauma, and age related orthopedic conditions, and the number of suppliers for the casting and splinting equipment and supplies market. Moreover, rising population and consistent efforts of key companies to develop sensors would also account for the market growth of the casting and splinting market. However, high cost and unfavorable reimbursement policies are likely to restrain market growth during the forecast period. The global casting and splinting market was valued at US$ 1,822.4 Mn in 2015 and is expected to reach US$ 3,105.2 Mn by 2024, expanding at a CAGR of 6.1% from 2016 to 2024.
Geographically, North America was the largest market for casting and splinting market in 2015. Increasing acceptance of technologically advanced casting and splinting and equipment such as cast cutters and fiberglass splint is one of the major factors supporting market growth. For instance, according to the International Osteoporosis Foundation (IOF), around 1.4 million individuals were affected with osteoporosis in Canada in 2010. The incidence rate of osteoporosis in Canada (according to the IOF 2014 report data from 2007) is one in four for women and one in eight for men, above 50 years of age. Thus, rising prevalence of these types of diseases propels the demand for casting and splinting in the U.S.
Europe comprises major countries such as Germany, France, the U.K., Spain, and Italy, along with other countries. In addition, consistent rise in the geriatric population in Europe boosts the growth of the casting and splinting market in the region. For instance, according to the International Osteoporosis Foundation, the region has the highest incidence rate of osteoporosis among adults, with Denmark, Sweden, Norway, and Switzerland leading the global osteoporosis incidence rate per 100,000 individuals. In addition, according to International Osteoporosis Foundation (IOF) estimates (based upon WHO diagnostic criteria), around 22 million elderly women and 5.5 million elderly men aged above 50 years are estimated to have osteoporosis (2010 estimate) and are expected to rise during the forecast period.
Asia Pacific comprises countries such as India, China, Australia, Japan, and Malaysia. The casting and splinting market in Asia Pacific is anticipated to witness the fastest growth rate during the forecast period owing to increased high frequency of road accidents and injuries, and ever-growing population in South Asia and China. According to the Association for Safe International Road Travel reported that over 90% of 1.3 million road fatalities occur in low- or middle-income countries of Asia, Africa, and Latin America. Furthermore, according to the International Osteoporosis Foundation (IOF), Asia is expected to have 50% of the world’s osteoporotic population by 2050. Large number of unreported cases, high incidence rate of Vitamin D deficiency, and low calcium intake by the population of Asia suggest that the region is likely to have the largest osteoporotic related fractures globally. This rapid growth in the osteoporotic population is anticipated to increase the demand for casts and splints in the region.
Further, Rest of the World comprises Latin America, Africa, and the Middle East. The number of vitamin D deficiency rickets in the Middle East and Africa is the highest in the world. The mortality rates post a hip fracture is two to three times higher than that in the West. These countries focus on improving health care infrastructure by increasing significant change in health care infrastructure and health care amenities along with increased awareness are bound to augment the diagnosis rate of osteoporosis and fractures. Besides osteoporosis, the other major factors for high demand of casting and splinting products include injuries due to civil violence and increased number of occurrences in these regions, especially in Middle East & Africa. The casting and splinting market in the region is therefore expected to rise during the forecast period from 2016 to 2024. This factor is anticipated to boost the casting and splinting market in Rest of the World.
3M Healthcare, BSN medical, DJO LLC, Ossur hf, Orfit Industries n.v., Stryker Corporation and others are some of the key players having presence in the global casting and splinting market.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Posted by at No comments:
Labels:

Women’s Health Rehabilitation Products Market: Rising Geriatric Population Boosts Demand for Treat Urinary Incontinence Products

According to a new market report published by Transparency Market Research “Women’s Health Rehabilitation Products Market (By Product – Orthopedic, Urinary incontinence, Pelvic Pain, Pregnancy and Post-partum, Breast Cancer, Lymphedema, and Osteoporosis): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024”, the women’s health rehabilitation products market is anticipated to expand at a CAGR of 5.0% from 2016 to 2024 to reach US$ 4.2 Bn by 2024.
Athletics, pregnancy, breast surgery, and osteoporosis could lead to musculoskeletal situations that cause weakness and pain. Hence, functional disability or impairment caused due to such conditions may affect the normal life of women in terms of mobility and social interaction. Women’s health rehabilitation programs are designed to mitigate the risk caused due to such deformities and help improve the health status through application of advanced therapies and treatments. Women’s health rehabilitation products help women to improve their health. Rehabilitation professionals such as physiatrists and physical therapists use rehabilitation products to help patients regain and maintain their health. Appropriate rehabilitative treatment and monitoring help improve musculoskeletal function, increase strength in supporting muscles, and restore proper functioning of the body.
Increased incidence and prevalence of deformities among women caused due to various factors such as breast cancer, urinary incontinence, pelvic pain, and lymphedema fuel the growth of the women’s health rehabilitation products market. Increase in awareness about the need for rehabilitation among women across the globe also boosts market growth. Demand for women’s health rehabilitation products is increasing globally due to rise in disease burden causing impairments among women. According to a report published by the WHO in 2013, rising maternal deaths were reported in developing countries, injuries due to road accidents are high in women in developed and developing countries, and cardiovascular disease is the primary cause of death among women. Major factors that contribute to increase in prevalence of physiological defects in women are growing geriatric population, rise in incidence of chronic diseases, and change in lifestyle, among others.
Rehabilitation is a highly monitored activity that assists in improving the health status of people suffering from various physical and mental problems. Rehabilitation programs include exercise training, monitoring of body vitals, education about healthy habits, and various other activities that help a patient to retain her health.
North America accounted for the largest share of 37.45% of the global women’s health rehabilitation market in 2015, followed by Europe. The dominance of these two regions is attributed to the aging population and increasing number of accidents in the past few years. However, the market in Asia Pacific is likely to expand at the highest CAGR during the forecast period. Factors such as untapped market and unmet needs for women’s rehabilitation products, developing health care infrastructure, and distribution and partnership strategies adopted by the key players support market growth in the region. According to the United Nations (UN), one in five women across the globe are affected with some kind of disability. The occurrence rate of disability among women is higher (19.2%) as compared to men (12%). High incidence rate of disability among women is expected to increase the utilization of rehabilitation products such as orthopedic and osteoporosis. Countries in Asia, especially India, China, and Japan, are witnessing the fastest growth in this sector due to favorable health care reforms, increase in disposable income, and rise in geriatric and disabled population. Hence, Asia Pacific is anticipated to become a potential market for women’s health rehabilitation products.
Access Health (Victoria, Australia), GE Healthcare (Chalfont St. Giles, U.K.), Carib Rehab Ltd. (St. Michael, Barbados), GPC Medical Ltd. (New Delhi, India), Meyer Physical Therapy (New York, U.S.), Pelvic Health and Rehabilitation (San Francisco, U.S.), Rehab Plus (Timmins, Canada), Sportstek (Oakleigh, Australia), Vandana Surgical Cotton Ind. (Ajmer, India), and Win Health Medical Ltd. (Jedburgh, U.K.) are the key players in the global women’s health rehabilitation products market.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Posted by at No comments:
Labels:

Hearing Aids Market Grows with Increasing Awareness Level Among Patients and their Families Regarding Hearing Impairment

Transparency Market Research has published a new market report titled, “Hearing Aid Market – (Therapeutic – Hearing Aids (Behind the Ear, Receiver in the Ear, In the Ear, and Canal Hearing Aids) and Bone Anchored Hearing Aids; End-user – Pediatric and Adult) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024.” According to the report, the hearing aids market is anticipated to expand at a CAGR of 4.5% from 2016 to 2024 to reach US$ 7.01 Bn by 2024.
Hearing aids are used for the treatment of profound hearing loss. Disabling hearing loss refers to hearing loss greater than 40 decibels (dB) in the better hearing ear in adults and a hearing loss greater than 30 dB in the better hearing ear in children. According to WHO estimates, there will be approximately 1.2 billion people over the age of 60 years with hearing disability by 2026. Hearing loss is one of the six leading global disease burden. Majority of people with disabling hearing loss live in low- and middle-income countries. Approximately one-third people over 65 years of age are affected by disabling hearing loss. The prevalence in this age group is highest in South Asia, Asia Pacific, and Sub-Saharan Africa.
Increasing global geriatric population and rising prevalence of deafness is expected to drive the global hearing aids market in the next few years. Moreover, rapidly increasing usage rate of digital hearing aid technology and patient awareness levels are expected to fuel market growth during the forecast period. Advances in hearing aids technology is expected to boost market growth during the forecast period. Rechargeable hearing aids that have quick charging and long lasting features are expected to offer considerable growth opportunities in the hearing aids market. Phonak Hearing Systems, a member of the Sonova Group, offers rechargeable hearing aids.
According to the U.S. National Center of Health Statistics (NCHS), 12 of 1,000 people in the U.S. suffering from hearing loss belong to the age group of below 18 years. The hearing aids market in the U.S. consists of both the private (approximately 79%) and public sector (approximately 21%), with the public sector dominated by the Veterans Affairs (VA). North America accounted for 29% share of the global hearing aids market in terms of revenue in 2015. According to Audiology World news, 2016, approximately 20% of the population of the U.S. with hearing loss use hearing aids. Increasing prevalence of hearing loss, aging population, and rising insurance coverage in the U.S. are some of the factors driving the hearing aids market in the country.
Europe held the largest share of the global hearing aids market in terms of both revenue and volume in 2015. Europe accounted for 39% share of the global hearing aids market in 2015. Presence of large geriatric population in countries in Western Europe, high purchasing power, and key players domiciled in the region are attributed to the considerable share of the region.
The market in Asia Pacific is expected to expand at the highest growth rate during the forecast period. Improving health care infrastructure, high unmet medical needs, and increasing patient disposable income are the factors driving the hearing aids market in Asia Pacific. The market in the region is likely to expand at a CAGR of 5.2% from 2016 to 2024.
Key players in the global hearing aids market include Sonova Holding AG, GN ReSound, Starkey, and Widex A/S.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Posted by at No comments:
Labels:

Steam Autoclave Market - Latest Innovations, Drivers, Restraints, Challenges and Forecast 2016 - 2024

The global steam autoclaves market is marked by intense competitive rivalry and high entry barriers for new vendors, typical of markets featuring high consolidation, reports a recent study by Transparency Market Research (TMR). The oligopolistic market witnesses the dominance of companies such as STERIS, Getinge Group, and Johnson & Johnson, which collectively held close to two-third of the overall market in 2015.
The presence of a very small number of product manufacturers, preference of buyers for long-term contracts with steam autoclave devices manufacturers, and broad product portfolios have further reinforced the standing of leading vendors in the market. Product innovations, production of economic products, and strategies aimed at expansion in emerging regional markets could aid small vendors in the market carve out new growth channels in the near future. Other notable vendors operating amid intense competition in the global steam autoclave market are 3M Health Care, Belimed Group, CISA Group, Matachana Group, CISA Group, and SAKURA SI CO., LTD.
Rising Number of Surgeries and Hospital-acquired Infections Stimulate Adoption of Steam Autoclaves in Healthcare Settings
The vast increase in the number of surgical procedures undertaken across the globe every year has played a major role in the increased consumption of steam autoclaves globally in the past few years. The Centers for Disease Control and Prevention states that in U.S. alone, nearly 46.5 mn surgeries and around 5 mn endoscopies are performed every year. In other regions as well, such as the developing parts of Asia Pacific, which are marked by large population bases and flourishing medical tourism industries, a massive rise in the number of surgical procedures has been seen in the past few years.
Compounding the need for effective sterilization mechanisms in healthcare settings in addition to abovementioned factor is the concern regarding rising prevalence of nosocomial infections across the globe. These factors, in addition to the rising focus on patient safety, will allow the global steam autoclave market gain traction in the next few years.
Technological Advancements to Fuel Market’s Growth
The market has witnessed the introduction of several technologically advanced and increasingly effective products such as E-beam and gamma irradiation, which are further boosting the market’s growth prospects. High product compatibility and low cost of these new products are expected to help the global steam autoclave market gain significant momentum over the forecasting horizon.
However, the increased usage of disposable devices across healthcare settings, which are not meant to be reused and require little or no sanitization over their usable life, could emerge as a major restraint for the overall growth of the market. Moreover, the imposition of excise duty taxes on the manufacturers of medical devices is also expected to hamper the overall profitability of steam autoclaves for vendors, thus resulting in increased product prices. This factor could also have a negative impact on the market’s growth prospects, especially in cost-sensitive developing regions.
In terms of popularity of product varieties available in the market, including traditional steam autoclaves and tabletop steam autoclaves, the market is again highly consolidated. The segment of traditional autoclaves accounted for a share of over 91% in the market in 2015. The segment is also expected to expand at the highest CAGR of 5.8% over the period between 2016 and 2024. North America was the leading regional market in 2015, with nearly 40% share in the market in terms of revenue in 2015.
On a whole, the global autoclave market was worth US$1.57 bn in 2015. Expected to rise at a healthy 5.7% CAGR from 2016 to 2024, the market is projected to touch US$2.57 bn by 2024.
This review is based on a latest market intelligence report published by Transparency Market Research, titled “Steam Autoclave Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”
Posted by at No comments:
Labels: , , , ,

Organ Preservation Solutions Market - Recommendations for 2016; Emerging Trends and New Technologies Research 2013 - 2019

Global Organ Preservation Solutions Market: Snapshot
The global market for organ preservation solutions is expected to witness substantial growth throughout the forecast period. The rising number of opportunities through strategic partnership with research organizations and medical institutions is projected to help the prominent players in expanding their consumer base. In addition, the growing focus on advanced in the medical sector is likely to contribute widely towards the development of the overall market in the next few years. However, the limited medical reimbursements for organ transplantation and donation are estimated to curb the growth of the overall market in the next few years.
According to the study, in 2012, the global market for organ preservation solutions was worth US$0.06 bn and is estimated to reach a value of US$0.20 bn by the end of 2019. Thanks to the rising awareness among consumers regarding the benefits of donation of organs, the global market is predicted to register a progressive 16.50% CAGR between 2013 and 2019.
Growing Awareness Concerning Organ Donation to Accelerate Growth
The rising NGO and government initiatives to encourage organ donation and the increasing number of solid-organ transplantation procedures are some of the vital factors expected to fuel the growth of the global organ preservation solutions market in the near future. Additionally, the tremendously rising cases of organ failures worldwide and technological developments in this field are predicted to supplement the growth of the market. However, the high cost of organ transplantation is estimated to restrict the growth of the market in the near future.
On the basis of solution, the global organ preservation solutions market has been divided into viaspan, RENOGRAF, hypoThermosol, custodiol HTK, PERFADEX, lifor human bioSystems, and siRNA Transplant Solutions. Furthermore, the key segments of the global organ preservation solutions market in terms of preservation are static cold storage, hypothermic perfusion preservation, and others. Innovations in the preservation methods is expected to offer promising opportunities for the leading market players.
Rising Number of Organ Donors to Supplement Growth of Europe Organ Preservation Solutions Market
From a geographical perspective, the global organ preservation solutions market can be divided into Europe, Asia Pacific, North America, and the Rest of the World. In 2012, Europe led the global market and is expected to remain in the leading position in the next few years. Thanks to the technological advancements in this field, the Europe market for organ preservation solutions is projected to register a progressive growth rate in the near future. In addition, the substantial contribution from Spain is expected to accelerate the growth of the market in the near future.
Furthermore, the rising number of organ donors and the policy of being an organ donor after death are some of the factors estimated to contribute towards the growth of the Europe market. The increasing awareness regarding the need for organ donation among the people and the rising number of initiatives taken by government to encourage organ donation are some of the other factors projected to fuel the growth of the market in the near future.
Some of the leading players operating in the organ preservation solutions market across the globe are Teva Pharmaceutical Industries Ltd., Claris Lifesciences Limited, BioTime, Inc., XVIVO Perfusion AB, Dr. Franz Köhler Chemie GmbH, Lifeline Scientific, CryoLife, Inc., ToleroTech, Inc., Bristol-Myers Squibb, BioLife Solutions, Inc., and 21st Century Medicine. The rising number of players in the market are projected to strengthen the competitive scenario of the global organ preservation solutions market in the next few years.
Posted by at No comments:
Labels: , ,

Prenatal and New-born Genetic Testing Market is progressing at a CAGR of 26.9% within a forecast period of 2013 to 2019

Global Prenatal and New-born Genetic Testing Market: Snapshot
Prenatal and new-born genetic tests refer to the systematic diagnostic tests and screenings undertaken to determine the risk of certain genetic disorders in newborn children and fetuses in stages as early as eight to ten weeks of gestation. The use of a variety of screening and diagnostic tools for detecting chromosomal abnormalities and the risk of diseases such as Patau syndrome, Down syndrome, and Edward syndrome is increasing at a significant pace across the world.
The vast rise in prevalence of genetic abnormalities and late pregnancies are some of the key factors to have led to an increased demand for prenatal and new-born genetic tests across the globe. The vast advancements observed in diagnostic and screening technologies and the rise in awareness about genetic diseases are also considered crucial to the rising demand for genetic tests in children, both before and after birth. Transparency Market Research states that the market will exhibit a remarkable 26.9% CAGR over the report’s forecast period.
Diagnostic Techniques to Continue to Remain Preferred Option for Detecting Chromosomal Abnormalities
The prenatal and newborn genetic testing market can be broadly segmented into screening techniques and diagnostics techniques. Of these, the segment of diagnostic techniques, covering popular genetic testing methods such as fluorescence in-situ hybridization (FISH), array comparative genomic hybridization (aCGH), and polymerase chain reaction (PCR), accounts for a massive share of the market.
Diagnostic techniques are expected to retain their position as the leading contributor of revenue to the global prenatal and newborn genetic testing market over the forecast period, owing to their more effective and accurate results as compared to screening techniques. Of the key genetic diagnostic techniques available in the market, PCR techniques are expected to be the most preferred owing to their high efficiency and varied applications.
Of the key prenatal and newborn genetic screening techniques commonly used across the globe, including maternal serum screening (MSS) and non-invasive prenatal testing (NIPT), the segment of non-invasive prenatal testing is expected to lead the market for prenatal and newborn genetic screening techniques. This is owing to the fact that non-invasive screening techniques completely eliminate the risk of miscarriage associated with invasive tests such as Chorionic Villus Sampling (CVS) and amniocentesis.
Emerging Markets to Present Most Lucrative Growth Opportunities
Presently, North America is the dominant market for the global prenatal and newborn genetic testing market, accounting for a massive chunk of the overall market. Apart from a large pool of highly-aware parents and a rising prevalence of genetic disorders in the region, the large number of companies operating in the diagnostics as well as screening sectors have also helped the prenatal and newborn genetic testing market strengthen its foothold in the region. Another developed region, Europe, is also a mature market for prenatal and newborn genetic testing.
However, in the next few years, the prenatal and newborn genetic testing market will witness the most traction across emerging regional markets such as Asia Pacific, and Middle East and Africa. The vast untapped opportunities in these regions and an encouraging rise in awareness about genetic testing, rising affordability, and increasing prevalence of genetic diseases will together contribute towards the healthy growth of the prenatal and newborn genetic testing market in these regions in the near future.
Some of the key vendors operating in the diagnostics field of prenatal and newborn genetic testing are Ariosa Diagnostics, Bio-Rad Laboratories, Perkin Elmer, and Agilent Technologies. Key vendors operating in the screening segment of prenatal and newborn genetic testing are Verinata Health and Sequenom, Inc.
Posted by at No comments:
Labels: , , ,

Synthetic Biology Market - Recommendations for 2016; Emerging Trends and New Technologies Research 2013 - 2019

Global Synthetic Biology Market: Snapshot
Organisms engineered with novel techniques of synthetic biology are more affordable as it increases the use of genetically modified microorganisms for various industrial applications and cuts down the cost of research. This is leading to the greater utilization of synthetic biology technologies and products by researchers across the globe. The growth of the global synthetic market is backed by the intervention of government bodies, universities, and large organizations in synthetic biology research activities.
Furthermore, the rapid advancements in technologies are working in favor of the growth of the market. According to a report by Transparency Market Research (TMR), the opportunity for the global market for synthetic biologics was worth US$5.48 bn in 2016 and is anticipated to rise at a tremendous CAGR of 32.6% from 2013 to 2019, reaching a valuation of US$13.37 bn by 2019.
Demand for Synthetic Biology Techniques to Remain High in Healthcare Sector Due to Rising Prevalence of Chronic Diseases
On the basis of application, healthcare will continue to account for the lion’s share of the overall market revenue throughout the forecast period. The rapidly growing global population along with the increasing incidence of chronic and infectious diseases is augmenting the growth of the segment. Synthetic biology has the potential to offer cost-effective and highly efficient drugs and vaccines with low side effects and enhanced nutrition. These drugs and vaccines can be used for the treatment of various diseases such as AIDS, cancer, malaria, and other infections. The agriculture segment is estimated to expand at a phenomenal CAGR of 52.5% during the forecast period owing to the ever-rising demand for food coupled with the declining availability of agricultural land.
Based on technology, genome engineering will continue to dominate the market until 2019. The technology is being increasingly adopted due to the fact that it helps in modifying a specific area of DNA, thereby offering better reproducibility. However, the biological components and integrated systems segment is poised to outpace other segments, progressing at a CAGR of 43.0% during the same period. The growth of this segment can be attributed to its potential of reducing the cost of producing large-scale biofuels and medicines.
North America to Outperform Europe Owing to Increasing Research and Development Efforts
Europe was the leading regional market in terms of revenue in 2016. The increasing government participation and funding for the development of synthetic biology are driving the growth of the region. Moreover, the growing applications of this technology in the field of health, energy, environment, and other areas are contributing to the growth of the region. However, the region is expected to lose its dominance to North America by the end of the forecast period.
The growth of the North America region can be attributed to the positive initiatives by government and private organizations to promote synthetic biology research activities. The rising scientific research and development of new technologies are expanding the scope for the development of synthetic biology in the region. Furthermore, the domicile of a large number of key players offers North America an edge over other regions. The region is anticipated to represent 46% of the overall market revenue by 2019.
On the other hand, Asia Pacific is likely to rise at a noteworthy CAGR of 34.2% during the same period. The immense growth potential in this region is attracting the support of many international organizations for the development of synthetic biology. The burgeoning demand for high-quality nutrition and cheap medicines among people is surging the demand for synthetic biology techniques and thus fuelling the market in the region. Some of the prominent players in the global synthetic biology market are Gevo Inc., Bristol Mayer, DSM, Life Technologies, DuPont Inc., LS9 Inc., Genomatica Inc., and Amyris Inc.
Posted by at No comments:
Labels: , , , , ,
Subscribe to: Posts (Atom)